FRANFORTE, ELISA
FRANFORTE, ELISA
Università degli Studi di UDINE
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
2020-01-01 Di Giorgio, E.; Dalla, E.; Franforte, E.; Paluvai, H.; Minisini, M.; Trevisanut, M.; Picco, R.; Brancolini, C.
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness
2017-01-01 Di Giorgio, Eros; Franforte, Elisa; Cefalù, Sebastiano; Rossi, Sabrina; Dei Tos, Angelo Paolo; Brenca, Monica; Polano, Maurizio; Maestro, Roberta; Paluvai, Harikrishnareddy; Picco, Raffaella; Brancolini, Claudio
The oncogenic role of class IIa HDACs in leiomyosarcomagenesis: HDAC9, a possible therapeutic target in leiomyosarcoma tumorigenesis.
2019-03-01 Franforte, Elisa
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription
2022-01-01 Minisini, Martina; Di Giorgio, Eros; Kerschbamer, Emanuela; Dalla, Emiliano; Faggiani, Massimo; Franforte, Elisa; Meyer-Almes, Franz-Josef; Ragno, Rino; Antonini, Lorenzo; Mai, Antonello; Fiorentino, Francesco; Rotili, Dante; Chinellato, Monica; Perin, Stefano; Cendron, Laura; Weichenberger, Christian X; Angelini, Alessandro; Brancolini, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells | 1-gen-2020 | Di Giorgio, E.; Dalla, E.; Franforte, E.; Paluvai, H.; Minisini, M.; Trevisanut, M.; Picco, R.; Brancolini, C. | |
| The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness | 1-gen-2017 | Di Giorgio, Eros; Franforte, Elisa; Cefalù, Sebastiano; Rossi, Sabrina; Dei Tos, Angelo Paolo; Brenca, Monica; Polano, Maurizio; Maestro, Roberta; Paluvai, Harikrishnareddy; Picco, Raffaella; Brancolini, Claudio | |
| The oncogenic role of class IIa HDACs in leiomyosarcomagenesis: HDAC9, a possible therapeutic target in leiomyosarcoma tumorigenesis. | 1-mar-2019 | Franforte, Elisa | |
| Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription | 1-gen-2022 | Minisini, Martina; Di Giorgio, Eros; Kerschbamer, Emanuela; Dalla, Emiliano; Faggiani, Massimo; Franforte, Elisa; Meyer-Almes, Franz-Josef; Ragno, Rino; Antonini, Lorenzo; Mai, Antonello; Fiorentino, Francesco; Rotili, Dante; Chinellato, Monica; Perin, Stefano; Cendron, Laura; Weichenberger, Christian X; Angelini, Alessandro; Brancolini, Claudio |